Strategies for the use of Ginkgo biloba extract, EGb 761^®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus

• Main Authors: Nagaendran Kandiah, Yee Fai Chan, Christopher Chen, Darwin Dasig, Jacqueline Dominguez, Seol Heui Han, Jianping Jia, Sang Yun Kim, Panita Limpawattana, Li Ling Ng, Dinh Toan Nguyen, Paulus Anam Ong, Encarnita Raya-Ampil, Nor'izzati Saedon, Vorapun Senanarong, Siti Setiati, Harjot Singh, Chuthamanee Suthisisang, Tong Mai Trang, Yuda Turana, Narayanaswamy Venketasubramanian, Fee Mann Yong, Yong Chul Youn, Ralf Ihl
• Other Authors: Chung-Ang University Hospital
• Format: Article
• Published: 2022
• Subjects: Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/78491
• Institution: Mahidol University

Background: Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementi...